DCA 2000 + MICROALBUMIN/CREATININE ASSAY— 510(k) K963142

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K963142 for DCA 2000 + MICROALBUMIN/CREATININE ASSAY, Substantially Equivalent on 1996-09-27. Applicant: Bayer Corp..

Clearance details

Applicant: Bayer Corp.
Product code: Code JIR
Advisory panel: Clinical Chemistry
Date received: 1996-08-13
Decision date: 1996-09-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Elkhart, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.